Yan Li

Dr. Yan Li


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2024 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
JLJingting Liu
Jingting Liu
YDYijun Dong
Yijun Dong
YZYawei Zhou
Yawei Zhou
WWWendi Wang
Wendi Wang
YLYan Li
Yan Li
JPJianying Pei
Jianying Pei
Observational epidemiological studies suggested that immunological dysregulation and inflammation play a significant role in the placental and renal dysfunction that leads to maternal hypertension. The immunophenotypes' possible causalities with hypertensive disease of pregnancy remain ambiguous. We performed two-sample Mendelian randomization (MR) analyses to comprehensively investigate the causal effect of immunophenotypes on hypertensive disorder of pregnancy (HDP). The large-scale genome-wide association studies (GWASs) data on immunological traits was taken from public catalog for 731 immunophenotypes. The summarized GWAS data in 4 types of HDP were retrieved from FinnGen database, including 811,605 Finnish individuals. The primary analysis was the inverse variance weighted (IVW) method, supplemented by conducting sensitivity analysis. To confirm whether cardiovascular proteins mediated the causal effect of immune cells on HDP, we additionally executed a mediation MR study. After looking into genetically predicted immunophenotype biomarkers, we discovered 14 highly correlative immunophenotypes and 104 suggestive possible factors. The IVW analysis indicated that HLA DR on myeloid DC, HLA DR on plasmacytoid DC, and HLA DR on DC had a significant association with pre-eclampsia/eclampsia (PE), whereas CD4+ CD8dim AC and CD4+ CD8dim % leukocyte were protective against gestational hypertension (GH). All of HDP in our study had no statistically significant impact on immune cells, according to reverse MR analysis. The mediating role of LOX-1between HLA DR on plasmacytoid DC and chronic hypertension prior to pregnancy was validated. This study showed that many immunophenotypes are implicated in HDP. Furthermore, the level of LOX-1 mediated the pathophysiology relationship between HLA DR on plasmacytoid dendritic cells and chronic hypertension prior to pregnancy.

17 September 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
JLJingting Liu
Jingting Liu
YZYawei Zhou
Yawei Zhou
YDYijun Dong
Yijun Dong
WWWendi Wang
Wendi Wang
YLYan Li
Yan Li
JPJianying Pei
Jianying Pei
Background: Studies using observational epidemiology have indicated that inflammation and immunological dysregulation are important contributors to placental and renal failure, which ultimately results in maternal hypertension. The potential causal relationships between the immunophenotypes and hypertensive disorder of pregnancy (HDP) are yet unclear.Methods: We conducted two-sample Mendelian randomization (MR) analyses to thoroughly examine the relationship between immunophenotypes and HDP. The GWAS data on immunological traits was taken from public catalog for 731 immunophenotypes and the summarized GWAS data in 4 types of HDP were retrieved from FinnGen database. The link between immune cell traits and HDP was examined through our study methodology, taking into account both direct relationships and mediation effects of apolipoprotein A (apoA). The inverse variance weighted (IVW) method served as the main analysis, while sensitivity analysis was carried out as a supplement.Results: We identified 14 highly correlative immunophenotypes and 104 suggestive possible factors after investigating genetically predicted immunophenotype biomarkers. According to the IVW analysis, there was a strong correlation between HDP and HLA DR on DC and plasmacytoid DC. Reverse MR analysis showed that there was no statistically significant effect of HDP on immune cells in our investigation. Mediation analysis confirmed that apoA mediates the interaction between HLA DR on DC and HDP.Conclusion: Our results highlight the complex interplay of immunophenotypes, apoA, and HDP. Moreover, the pathophysiological link between HLA DR on DC and HDP was mediated by the level of apoA.

17 April 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
JLJingting Liu
Jingting Liu
YZYue Zhao
Yue Zhao
CZChong Zhang
Chong Zhang
JPJianying Pei
Jianying Pei
YLYan Li
Yan Li
Preeclampsia (PE) is a complex hypertensive disorder of pregnancy characterized by new-onset maternal hypertension and multi-organ dysfunction. Although placental maladaptation and immune activation are well-established features of PE, growing evidence indicates that dysregulated neuro–immune–vascular integration critically contributes to disease initiation, progression, and long-term sequelae. Normal pregnancy requires coordinated immune and neural adaptations, particularly at the maternal–fetal interface, to support successful placentation. While placental pathology, angiogenic imbalance, and immune activation establish the systemic environment of PE, some neurological phenotypes (such as eclampsia and acute cerebral autoregulatory failure) are difficult to explain without involvement of central autonomic and sensory integration circuits that mediate the translation of peripheral inflammatory and vasoactive signals into neurovascular responses. Dysfunction of cerebral autoregulation has been proposed as a key mechanism underlying acute neurological complications, independent of classic placental factors. In PE, this finely tuned communication becomes spatially and functionally disrupted, triggering cascades of inflammatory and vascular pathology. Emerging studies suggest that neural signals, including autonomic activity and neuropeptide signaling, may modulate local immune phenotypes and vascular responses, thereby sustaining feed-forward cycles of inflammation and endothelial dysfunction. Altered neural inputs to peripheral immune organs may further bias myelopoiesis and amplify systemic inflammatory burden. At the central nervous system level, persistent neuroinflammation and blood–brain barrier disruption may potentiate systemic inflammatory signals, contributing to acute neurological manifestations and increased long-term cerebrovascular risk in women with prior PE. This review synthesizes evidence from human studies and experimental models to delineate neuroimmune mechanisms implicated in PE, identifies critical gaps in current knowledge, and highlights emerging concepts such as neuroimmune memory and neuro–metabolic crosstalk. We further discuss translational opportunities, including biomarker discovery, neuro-modulatory interventions, and advanced approaches such as single-cell and spatial omics. By integrating classical immunovascular paradigms with emerging neuroimmune insights, we propose a more comprehensive framework for understanding PE pathogenesis and for developing novel diagnostic and therapeutic strategies.

29 May 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
FLFeifan Leng
Feifan Leng
RXRuiying Xia
Ruiying Xia
JPJianying Pei
Jianying Pei
YSYuzhe Shi
Yuzhe Shi
CGChenjie Gao
Chenjie Gao
YLYan Li
Yan Li
Breast cancer metastasis remains the leading cause of cancer-related mortality and is closely linked to immune evasion and tumor microenvironment (TME) remodeling. Emerging evidence suggests that intratumoral microbiota (ITM), typically low in biomass and predominantly intracellular, may be associated with tumor progression. This review summarizes the compositional features of ITM and their potential roles in metastasis, including epithelial–mesenchymal transition (EMT), circulating tumor cell (CTC) survival, pre-metastatic niche formation, and distant colonization. Mechanistically, ITM may influence these processes through immune-related signaling pathways (e.g., PRR-mediated cascades) and modulation of immune cell function. However, current evidence is largely derived from preclinical or correlative studies, and causal roles in human breast cancer remain unproven. Methodological challenges associated with low biomass further complicate interpretation. We also discuss microbiota-targeted strategies, including probiotics, antibiotics, and fecal microbiota transplantation, which remain experimental. Future studies using rigorous methodologies and longitudinal human data are required to clarify the role of ITM and its clinical potential.

19 June 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
JLJingting Liu
Jingting Liu
CZChun Zhang
Chun Zhang
CZChong Zhang
Chong Zhang
JPJianying Pei
Jianying Pei
YLYan Li
Yan Li
The interplay between the nervous and immune systems has attracted growing scientific attention due to its implications for tumor progression, immune regulation, and potential therapeutic strategies. Although their primary concentration is on inflammation and homeostasis, this basic information emphasizes the crucial role that neuro-immune interaction plays in disease states, including cancer. Neuro-immune interactions are complex and multifaceted, playing significant effects on the pathophysiology of cancer. These interactions involve both peripheral and central neural pathways, modulating immune cell activity within the tumor microenvironment, and offering promising avenues for innovative therapeutic interventions. This review synthesizes recent advancements in understanding the molecular mechanisms, regulatory pathways, and translational applications of the neuro-immune axis in cancer. We explore the intricate roles of neurotransmitters, cytokines, and neurotrophic factors in mediating this crosstalk, examining how the peripheral, central, and enteric nervous systems regulate tumor immunity. Furthermore, we explore emerging therapeutic strategies that target neural inputs, combine neuroimmune modulation with immunotherapy, and consider the impact of epigenetic regulation on the neuroimmune microenvironment. By synthesizing recent advances, this review aims to provide a comprehensive understanding of this intricate field, identify current challenges, and delineate future research directions to harness neuro-immune modulation for offering promising avenues for innovative therapeutic interventions.